Baird Capital co-leads Strata Oncology's $12M Series A financing

Ann Arbor-based Strata Oncology, a precision medicine company, completed a $12M Series A financing, co led by Arboretum Ventures and Baird Capital, with additional funding provided by Strata's existing investor, Michigan eLab. The financing will fuel Strata's state-of-the-art tumor sequencing operation and implementation of the Strata Trial, a nation-wide effort aimed at substantially increasing the number of enrollments in precision medicine clinical trials. 

For more information, please read Strata's news release